S 7668

New York Senate bill in Session 2025-2026.

Status: in_committee. Latest action: January 7, 2026.

Prohibits the sale of xylazine above a certain weight.

Bill ID NY-2025-2026-S-7668

Session 2025-2026

Status in_committee

Committee Consumer Protection

Senate in_committee 2026-01-07

Summary

Prohibits the knowing sale of xylazine above a certain weight to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Sponsor

Nathalia Fernandez

Official Source Back to Bills

Actions Timeline

Date	Event	Detail
2025-04-28	Introduced	Bill introduced
2026-01-07	Status	in_committee
2026-01-07	Latest Action	In Senate Committee

More Bills From This Sponsor

S 1819

Provides that the results of urine tests conducted pursuant to a judicial diversion program shall be private and confidential

in_committee • Senate

S 9272

Relates to expanding opioid overdose prevention measures in certain settings

passed_lower • Senate

S 1763

Relates to cost sharing fees for outpatient treatment at a substance use treatment program

in_committee • Senate

S 10156

Establishes a school speed zone camera demonstration program in the village of Pelham

in_committee • Senate

S 10632

Prohibits the use of intoxication of the victim as a defense in sex crimes

in_committee • Senate

S 9093

Establishes a lesbian, gay, bisexual, transgender, queer or questioning plus crisis hotline

in_committee • Senate